ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2024

News provided by

06 May, 2024, 08:21 GMT

Zinzino group revenue increased with a total of 35 %, compared with the previous year.

GOTHENBURG, Sweden, May 6, 2024 /PRNewswire/ -- The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK 163.7 (121.2) million compared with the previous year.

Accumulated revenue for January – April 2024 increased by 20 % to SEK 618.2 (514.9) million.

Revenues were distributed as follows:

Regions,MSEK	24-Apr	23-Apr	Change	YTD 2024	YTD 2023	Change
The Nordics	24.7	21.5	15 %	92.8	95,0	-2 %
Central Europe	44.9	29.3	53 %	164.4	120.2	37 %
East Europe	31.1	30.6	2 %	124.9	123.1	1 %
South & West Europe	25.5	15.6	63 %	96.1	64.7	49 %
The Baltics	8.1	7,0	16 %	32,0	28.1	14 %
North America	15.0	5.8	159 %	50.4	25.4	98 %
Asia-Pacific	5.3	5.2	2 %	17.6	20.8	-15 %
Africa	1.1	1,0	10 %	4.4	4.8	-8 %
Zinzino	155.7	116.0	34 %	582.6	482.1	21 %
Faun Pharma	8,0	5.2	54 %	35.6	32.8	9 %
Zinzino Group	163.7	121.2	35 %	618.2	514.9	20 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa